Application no. and date | 14743689.3 (espacenet) (Federated) (European Patent Register), 20140127 | Patent/reg. no. and date | DK/EP 2948441, 20171227 | Publication date | 20151202 | Priority no. and date | KR 20130009282, 20130128 | EP pub. no. and date |
EP 2948441 20151202 | Effective date | | Applicant/owner | Hanmi Pharm. Co., Ltd., 214 Muha-ro Paltan-myeon Hwaseong-si
Gyeonggi-do 445-910, KR | Applicant ref. no. | V1802-073-DK | Inventor | BANG, Keuk Chan, 4304-501 2 Gwanggyomaeul-ro Suji-gu
Yongin-si Gyeonggi-do 448-130, KR, JUNG, Jae Hyuk, 302-ho 65 Guksabong 10-gil Dongjak-gu
Seoul 156-846, KR, MOON, Young Ho, 146-1203 498 Yeongtong-ro Yeongtong-gu
Suwon-si Gyeonggi-do 443-740, KR | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | Opponent | | IPC Class | A61K 31/517 (2006.01) , A61P 35/00 (2006.01) , C07D 401/12 (2006.01) | Title | FREMGANGSMÅDE TIL FREMSTILLING AF 1-(4-(4-(3,4-DICHLOR-2-FLUORPHENYLAMINO)-7-METHOXYQUINAZOLIN-6-YLOXY)PIPERIDIN-1-YL)PROP-2-EN-1-ON | Int. application no. | KR2014000752 | Int. publication no. | WO2014116070 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|